The data was presented today by Dr. Jacob Sands, Dana-Farber Cancer Institute in Boston, Mass., at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer.
Patients with advanced non-small cell lung cancer have limited treatment options after lung cancer progresses on first-line therapies. Datopotamab deruxtecan (Dato-DXd) is a novel trophoblast cell surface antigen 2-directed antibody-drug conjugate under clinical evaluation in multiple solid tumor types.
The pivotal TROPION-Lung01 trial in patients with previously treated advanced NSCLC had met its dual primary endpoint of improved progression-free survival versus docetaxel (hazard ratio [HR] 0.75; 95% CI, 0.62-0.91; P=0.004). Superior efficacy outcomes were observed with Dato-DXd in patients with non squamous lung cancer.
“Dato-DXd did not meet its overall survival endpoint, but the therapy has many positive upsides that make it an option for some patients with non-squamous NSCLC,” said Dr. Sands pointing out the multiple improved outcomes in the non-squamous group for Dato-DXd vs docetaxel including response rate (31.2% vs 12.8%), median PFS (5.5 vs 3.6 months), and a trend of improvement in OS (14.6 vs 12.3 months).
Dr. Sands reported baseline characteristics were balanced between arms, and median follow-up was 23.1 months for both treatment arms. Median overall survival was 12.9 months (95% CI, 11.0-13.9) with Dato-DXd versus 11.8 months (95% CI, 10.1- 12.8) with docetaxel (HR 0.94; 95% CI, 0.78-1.14; P =0.530) in the full analysis set.
However, Dr. Sands said that median overall survival was numerically longer in the prespecified nonsquamous subgroup with 14.6 months (95% CI, 12.4-16.0) with Dato-DXd vs 12.3 months (95% CI, 10.7-14.0) with docetaxel( HR 0.84; 95% CI, 0.68-1.05).
“The overall safety and efficacy profile of Dato-DXd supports its use as a potential new therapeutic option for patients with nonsquamous NSCLC who are eligible for subsequent therapy,” said Dr. Sands.
About the IASLC: The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association’s membership includes more than 10,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit http://www.iaslc.org for more information.
About the WCLC: The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting nearly 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2024.iaslc.org.
In the workshop, attendees will learn how to execute social media campaigns with measurable impact that achieve specific objectives that are clearly established. Participants will discover the differences in organic social media marketing versus paid social media efforts to drive donations, especially surrounding events like #GivingTuesday and other significant fundraising events for your nonprofit.
“I was so excited to receive the registration list and see some of the most prominent nonprofit organizations listed. I get great joy knowing that the social media skills I’ll be sharing in this three-hour, in-person workshop will have such a positive impact in our community and beyond. These strategies will help our nonprofit leaders to have more fundraising success and recruit more volunteers thus extending their reach with the amazing work they do at their respective organizations,” said Carnett, Faculty, Center for Nonprofit Leadership, California Lutheran University.
Learning outcomes from the three-hour in-person workshop include the following: 1. Identification of goals surrounding the utilization of social media marketing for your nonprofit (i.e. recruit volunteers, attract full-time staff, engage corporate donors, cultivate individual donors or promote upcoming fundraising events) 2. Clarity on the use cases for each social media platform as it relates to the objectives of your nonprofit. 3. Best practices in streamlining the development, editing, and scheduling of your social media content calendar utilizing social media scheduling tools with metrics. 4. Leveraging social media marketing as a component of a larger marketing or development campaign (i.e. collaborations with more highly visible creators and utilization of relevant hashtags). 5. Communicating social media impact to your Executive Leadership Team, Board, corporate donors or individual donors in alignment with your nonprofit fundraising objectives and mission match.
“The reach that social media provides makes it an essential tool for nonprofits to communicate with their audience and mobilize support. Yet, few nonprofits effectively leverage this opportunity. The CLU Center for Nonprofit Leadership is excited to offer this workshop with Lindsey Carnett to explore how nonprofits can harness the power of social media to increase organizational visibility, draw volunteers and supporters to their cause, and meaningfully convey mission-related messages,” said Brewster King, MBA, Associate Director, Center for Nonprofit Leadership, California Lutheran University.
California Lutheran University has just announced that Carnett, Faculty for California Lutheran University Center for Nonprofit Leadership, has joined its Board of Directors for the Community Leaders Association (CLA).
Please register here: Center for Nonprofit Leadership (neoncrm.com) The event is free to members of the Center and $55 for nonmembers. The CLU Oxnard Campus is at 2201 Outlet Center Drive.
About Lindsey Carnett:
Lindsey Carnett is a marketing and public relations professional who developed The Marketing Maven Method to simplify marketing by empowering leaders to make data-driven marketing decisions. Carnett is the CEO of Marketing Maven, a research, digital and PR firm headquartered in Ventura County, and author of the recent book, The Marketing Maven Method: Secrets of a Maven.
A two-time honoree of Inc. 5000 Fastest Growing Independently Owned Companies in America, as well as an Entrepreneur 360 Most Entrepreneurial Companies in America award recipient, Lindsey has taken her business expertise global to enlighten marketing peers and business leaders about best practices in using PR to drive engagement, improve organic SEO, and grow a positive online reputation.
Having spoken at high profile national marketing and consumer products conferences and guest lectured at universities, Carnett has gained the reputation as an expert in the field of marketing and public relations. Her areas of specialties include: Public Relations, Social Media, Reputation Management, Direct Response Marketing, U.S. product launches, SEO, Market Research, and Spanish Media.
About The California Lutheran University Center for Nonprofit Leadership:
Since 1991, the Center for Nonprofit Leadership has been the point of convergence serving nonprofit leaders and organizations serving the region. As the only management training center of its kind in Ventura County, the Center has earned a reputation as the one-stop source for excellence in nonprofit leadership. It is the one place in Ventura County that provides a comprehensive approach to sustaining nonprofit-specific organizational and leadership development.
Through a broad array of programming that is accessible, relevant, timely and adaptive to the current needs of leaders and organizations, the Center plays a critical role in the organizational and leadership development of the nonprofit sector in Ventura County. By entrusting their time, energy and resources with us, leaders will attain higher levels of skills and capacity, and nonprofit organizations will achieve a higher level of efficiency and effectiveness. The success of the Center is tied closely with its role in the overall nonprofit ecosystem, where the Center wears multiple hats: as player and coach, leader and community partner, as well as provider of unbiased information and community data. We keep our finger on the pulse of the trends affecting the sector and adapt programming to reflect both best practices and emerging trends.
Skills-building opportunities provide a combination of hands-on management tools and peer networking opportunities that help nonprofit leaders strengthen skills and make valuable contacts for future collaboration. Faculty members are subject matter experts and respected leaders in their fields who provide practical perspectives that can be put to use immediately. Workshops are facilitated based on best practices of adult learning with the intent of fostering an adult co-learning environment where ideas are shared and resources optimized.
A byproduct of the Center’s learning model is the collaborative co-learning environment in which the faculty not only provides content expertise but also fosters co- learning and sharing among attendees. Attendees learn as much from each other as they do from subject matter experts, particularly organizational change strategies and how best to leverage new found skills and relationships in their daily work.
Recent air pollution exposure in the form of particles smaller than 2.5 micrometers (PM2.5) exposure may significantly impact lung cancer in women who have never smoked, with notable differences in stage IV diagnoses among EGFR+ patients, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer.
SAN DIEGO, Sept. 10, 2024 /PRNewswire-PRWeb/ — Recent air pollution exposure in the form of particles smaller than 2.5 micrometers (PM2.5) exposure may significantly impact lung cancer in women who have never smoked, with notable differences in stage IV diagnoses among EGFR+ patients, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer.
The International Agency for Research on Cancer (IARC) categorized outdoor air pollution and its key component, particulate matter PM2.5, as Group 1 carcinogens in 2013, indicating that they cause lung cancer. Associations between tobacco use and lung cancer account for a majority of lung cancers. Still, researchers and public health experts have not been able to identify an association that explains why individuals who do not smoke or have never smoked are diagnosed with lung cancer.
“The timing and duration of PM2.5 exposure that are most relevant for the development of lung cancer and lung cancer risk have not been well characterized. The purpose of our study is to compare the associations between recent versus long-term cumulative PM2.5 exposure in men and women who had never smoked and lung cancer EGFR mutation status,” said Dr. Yixian Chen, a researcher at British Columbia Cancer Research Institute, Vancouver, Canada.
The research team collected data from newly diagnosed lung cancer patients who never smoked that included information on their residential history from birth to the date of diagnosis. Dr. Chen and the team then geocoded each residential address and analyzed high-resolution concentration estimates of PM2.5 exposure from satellite data, chemical transport models, and ground measurements within roughly 10 x 10 kilometer areas corresponding to the time the individual lived at each address. The team obtained annual exposure data going back to 1996 when accurate air pollution information became available globally.
A total of 255 patients with known EGFR mutation status were included in the analysis. Significant associations were observed between EGFR mutation and cancer stage among women (p=0.197 in men, p less than 0.001 in women). Patients diagnosed with stage IV lung cancer displayed higher proportions of EGFR mutations compared to those without. Notable differences were also identified in the cumulative 3-year PM2.5 exposure before diagnosis in women who never smoked with EGFR mutations compared to those without (e.g., 19.0 vs 17.3 μg/m3, p=0.031). This trend persisted when examining cumulative 5-year exposure (33.7 vs 29.5 μg/m3, p=0.024) before diagnosis, with higher exposure observed in the EGFR-mutation positive group (EGFR+). Surprisingly, these associations were not evident in men who never smoked. Moreover, long-term exposure, such as 10-, 15-, and 20-year cumulative exposure to PM2.5, was not associated with EGFR mutation status in either men or women.
“These findings suggest a potential impact of recent exposure to PM2.5 on lung cancer in people who never smoked, particularly among women, with significant differences in stage IV diagnoses among EGFR+ patients,” said Dr. Chen. “Further studies are needed to confirm if PM2.5 measurement over 3 to 5 years is adequate for lung cancer risk assessment.”
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association’s membership includes more than 10,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit http://www.iaslc.org for more information.
About the WCLC: The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting nearly 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2024.iaslc.org.
The Quinton lab and manufacturing site, just 25 km (15 miles) from the Mediterranean, sources seawater from the pristine Bay of Biscay, 680 km (423 miles) away. This remote, deep-water location is chosen for its rich mineral content and minimal pollution, ensuring high nutrient bioavailability and rigorous testing for contaminants. Seawater is extracted from select locations and transported in refrigerated trucks to Quinton Laboratories, where it undergoes rigorous testing and patented double cold microfiltration to ensure purity and to preserve its natural qualities. Over 100 parameters are tested throughout production to ensure the highest quality of Quinton products.
While Quinton® Totum Sport hypertonic products are comprised of 20mL of raw mineral-rich seawater that has been expertly microfiltered to remove impurities, Quinton® Totum Nite isotonic products undergo a delicate process of combining 25mL of mineral-rich hypertonic solution with natural spring water to match the solute concentration of human cells and allow for easier absorption.
Quinton® Totum Sport and Quinton® Totum Nite are Informed Sport Certified and meet the highest benchmarks for quality and purity, with thorough testing for banned substances. This certification makes it a trusted choice for athletes and serious competitors around the globe.
“Ditch the sugar-laden electrolyte drinks and experience the power of Quinton® Totum Sport and Quinton® Totum Nite, all-natural, nutrient-dense, and naturally sugar-free alternatives,” Dr. Shade laments. “Each sachet, containing pure seawater, is crafted to support intense training, recovery and focus, helping athletes perform at their best when it matters most.”
“As a lifetime athlete competing at the highest level in my sport I have struggled with dehydration, including two trips to the hospital for full body cramps. Quinton is truly the magic bullet when it comes to keeping your body hydrated at the cellular level,” says Eben Bitton, former NFL offensive tackle. “Not only do I no longer suffer from cramping muscles, but my performance has been optimized on every level from sustained mental sharpness and concentration, muscular durability and cardiovascular capacity. Quinton will forever be a mainstay in my daily supplementation.”
Quinton® Totum Sport and Quinton® Totum Sport Nite come from Laboratories Quinton in Spain, using protocols established in 1887, where the ocean water is cold micro-filtered to the highest purity to maintain the mineral profile innate to seawater. The isotonic and hypertonic formulas ensure the minerals and trace elements are quickly absorbed, helping athletes to recover faster, rehydrate more efficiently and reduce fatigue. Quicksilver Scientific is the only licensed North American distributor of Quinton® Totum Sport and Quinton® Totum Nite.
For more information on Quinton® Totum Sport and Quinton® Totum Nite, including details on its health benefits and purchasing options, visit the Quinton Sport page here.
About Quicksilver Scientific
Quicksilver Scientific, Inc. is a leading manufacturer of premium nutraceuticals and the exclusive North American distributor of Quinton products which include the Quinton, Quintessential and Quinton Sport brand Our mission: combine nature’s nutrients with innovative science to empower people’s health journey. We’ve pioneered a holistic solution to meet any modern health goal: testing that identifies toxicity levels; professional protocols that help detoxify the body; and an evolving pharmacy of liposomal supplements. Quicksilver Scientific’s advanced nanoparticle technology has resulted in the world’s most sophisticated liposomal delivery system — solving the industry’s “bioavailability problem” by sending the highest-quality nutrients into the cells for more direct absorption.
Our award-winning products and protocols are used by practitioners and consumers worldwide. From our Colorado headquarters and cGMP-certified lab, we quality control every batch and third-party test to meet safety and potency standards of the R&D and manufacturing processes. At Quicksilver Scientific, we’re inspired by nature. Powered by science. And committed to improving the well-being of everyone we touch.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
“Whether it’s demonstrating a classic dish like Bananas Foster or handcrafting homemade seasonal soups, our communities make dining an experience our residents look forward to each day,” said John Hartmayer, chief operations officer and executive vice president of Benchmark. “For the second straight year, we’re delighted to demonstrate what senior living dining can and should be.”
On Sept. 21 at 4PM, Benchmark’s regional director of dining services and chef, Michael Eckrote, will be partnering with wine experts to lead Aged to Perfection: Culinary Seminar and Wine Pairing. The sold-out event will feature the artful dining experiences enjoyed by Benchmark residents perfectly paired with four different wines.
At the Tasting Tent, occurring each day of the Festival, Benchmark chefs will also be preparing and serving two carefully created dishes, an iced Autumn Cider Mocktail featuring Kombucha and warm Apple Fritters. These dishes will be prepared by acclaimed Benchmark chefs Robert Freemer III from Blenheim-Newport, a restaurant and resort chef and former owner of Happy Hollidays in Westerly with 35 years’ experience, David Silva, an award-winning chef who has been with Capitol Ridge at Providence for over 25 years and William Bonniol, Jr., from Greenwich Farms at Warwick, a Johnson & Wales graduate and Benchmark veteran known for his bold Italian food.
Benchmark is New England’s largest senior living provider with 66 independent living, assisted living, memory care and continuing care communities and over 6,700 dedicated associates providing compassionate care and outstanding experiences throughout the Northeast. The Waltham, Mass.-based company was founded over 27 years ago by Tom Grape with the purpose of Transforming Lives Through Human Connection. Since then, Benchmark has continued to set the industry standard, having won over 300 hundred local, regional and national awards for its care, programs and as a top workplace. Benchmark has been named one of the Top Places to Work for 16 straight years in The Boston Globe’s annual employee-based survey and received repeated recognition in FORTUNE’s Best Workplaces for Aging Services list. In 2024, Benchmark communities received 62 U.S. News & World Report Best of Senior Living excellence awards based on resident and family feedback. For more information, visit BenchmarkSeniorLiving.com.
The initiative encourages participants to pair peer-to-peer fundraising with a daily movement challenge to raise funds to support cerebral palsy research and assistive technology.
NEW YORK, Sept. 10, 2024 /PRNewswire-PRWeb/ — Cerebral Palsy Alliance Research Foundation (CPARF) announced today that all donations will be matched up to $80,000 in its ninth annual STEPtember campaign. Through September 30, participants can take 10,000 “steps” daily by doing over 80 activities while raising funds through the support of family, friends, colleagues, and more for cerebral palsy research and assistive technology for all disabled people through the Remarkable US accelerator.
The funds raised through STEPtember power CPARF’s work to change what’s possible for people with cerebral palsy and other disabilities through its support of the best and brightest researchers looking into cerebral palsy in adulthood, genomics, chronic pain, regenerative medicine, early detection and early intervention, and technology. CPARF is currently funding more than 40 research projects and has provided seed funding and mentorship to 14 startups since the Remarkable US accelerator program began in 2022.
“One million people in the US alone live with cerebral palsy and 1.3 billion people around the world have a disability,” said Chris Olver, CPARF’s Executive Director. “CPARF’s initiatives like STEPtember allow participants to get involved in a way that works for them — any skill level or ability — to support our work and move cerebral palsy research and assistive technology development forward.”
10,000 individuals and 1,800 teams are already “stepping up” to the challenge, and you can sign up at any time during the month by registering at steptember,us.
About Cerebral Palsy Alliance Research Foundation: Cerebral Palsy Alliance Research Foundation funds US-based research to change what’s possible for people with cerebral palsy, implements proven science, empowers people through education, and advances technology benefiting all disabled people worldwide. Learn more at cparf.org.
Attendees will also learn how ancillary imaging procedures, such as radiographic fracture analysis, micro computed tomography (microCT) and scanning electron microscopy (SEM), affect sample selection, tissue preservation and relate to histopathology evaluation.
The expert speaker will share recommended best practices for protocol development and pathology-driven tasks appropriate for medical device studies run under good laboratory practices (GLP), in accordance with ISO 10993-6 and in non-GLP environments.
Examples will be provided from a range of study types to illustrate strategies for selecting suitable controls, collecting appropriate tissues and designing applicable histopathology scoring. In addition, attendees will receive practical tips on avoiding common pitfalls that might compromise pathology success.
Register for this webinar today to learn how preclinical medical device studies can be optimized and how successful outcomes can be ensured for medical device research.
Join Dr. Lynette Phillips, Senior Pathologist, StageBio, for the live webinar on Wednesday, September 25, 2024, at 10am EDT (4pm CEST/EU-Central).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
“I look forward to continuing to deliver outstanding results and helping patients achieve their aesthetic goals. The majority of my patients live in this region of San Diego or travel from Los Angeles and Orange County, so the new location simply made sense,” says Dr. John Hilinski.
More about Dr. John Hilinski:
Dr. John Hilinski is a double-board certified facial plastic surgeon who attended Harvard Medical School. After graduation, he completed a general surgery internship followed by a Head and Neck Surgery residency at the University of California, San Diego (UCSD) Medical Center. Throughout his residency, Dr. Hilinski focused his efforts exclusively on surgery of the face and neck. Such specialty training and experience provided him with an unparalleled foundation to become a facial plastic surgeon. Dr. Hilinski was chosen for a prestigious Facial Plastic & Reconstructive Surgery fellowship sponsored by the American Academy of Facial Plastic and Reconstructive Surgery. He completed his fellowship in Chicago, Illinois, under the direction of internationally renowned facial plastic surgeon Dean M. Toriumi, M.D. In conjunction with his training, Dr. Hilinski served as a Clinical Instructor in the Division of Facial Plastic and Reconstructive Surgery at the University of Illinois, Chicago College of Medicine. During his fellowship, Dr. Hilinski learned the latest advancements in facial plastic and reconstructive surgery, encompassing all aspects of cosmetic facial enhancement. In addition, he is a member of the American Academy of Facial Plastic and Reconstructive Surgery as well as the American Academy of Otolaryngology-Head and Neck Surgery. Dr. Hilinski has also published numerous journal articles and book chapters on a variety of topics in facial plastic surgery. For more information or to schedule a consultation with Dr. John Hilinski, please call 619-296-3223 or visit http://www.drhilinski.com.
“It’s exciting to be able to offer our care services in Oklahoma, which happens to be my home state,” said Kelly Mitchell, Chief Executive Officer and Founder of Heart to Heart Hospice, who is from Sallisaw. “We are anxious to begin serving patients and families in this area and to provide the compassionate care and support they deserve.”
Heart to Heart Hospice, based in Plano, Texas, has been serving patients with life-limiting illnesses, as well as their loved ones, since 2003. The company currently provides a broad range of hospice services across 63 locations in Indiana, Michigan, Oklahoma, and Texas.
“When medicine cannot provide a cure, hospice redefines hope in terms of a patient’s quality of life,” said Robert Watson, who will serve as the Executive Director of the new Oklahoma location. “We care for the whole person through a team-oriented approach, meeting each patient’s unique needs,” he noted. “We also support their caregivers with guidance and encouragement, to help make the time together as peaceful as possible.”
Watson said Heart to Heart Hospice of Southeast Oklahoma, slated to open later this fall, is currently in the process of staffing. The new facility is located at: 1321 N. 16th Avenue, Durant, OK 74701. Phone: 580.634.7127.
“Helping our patients remain in the place they call home and keeping them comfortable is what the Heart to Heart care team is trained to do,” said Tracy Sudduth, MSN, RN, CHPN, and Chief Clinical Officer of Heart to Heart Hospice. “We develop a personalized care plan that will honor their wishes and values and truly make a difference for them and their families.”
About Heart to Heart Hospice Heart to Heart Hospice, founded in 2003, is one of the largest private providers of hospice care in the United States. Headquartered in the Dallas-Fort Worth Metroplex, Heart to Heart provides a broad range of hospice services to patients with life-limiting illnesses across 63 locations in Indiana, Michigan, Oklahoma, and Texas. At Heart to Heart, we understand both the physical and emotional challenges for our patients and their loved ones, and our compassionate care team is committed to providing them with what they need most: comfort, support, and dignity. Learn more about Heart to Heart Hospice here: https://hearttohearthospice.com/.
Media Contact
Kim Dellinger, Heart to Heart Hospice, 972.517.6300, [email protected], hearttohearthospice.com
Torrance Dentistry, a highly esteemed family dental practice, is dedicated to restoring and enhancing smiles for patients of all ages. Led by Dr. Steve Yabuno and Dr. Daniel Yabuno, the clinic employs conservative, cutting-edge procedures to achieve beautiful, long-lasting results.
TORRANCE, Calif., Sept. 10, 2024 /PRNewswire-PRWeb/ — Torrance Dentistry offers a broad spectrum of services, ensuring that all dental needs are met under one roof. Whether patients require a routine check-up, are considering cosmetic dental procedures or need specialized oral health care, the practice provides exceptional service. With periodontists on staff, advanced treatments are conveniently available in the office, offering a comprehensive and seamless experience. Torrance Dentistry has been recognized as a 2024 Top Patient Rated Dentist as a direct result of the clinic’s commitment to excellence, earning five-star ratings and superior online reviews. Find Local Doctors is a trusted online directory that helps patients locate qualified and reputable physicians and dentists in their area. The experienced team at Torrance Dentistry provides full-service dentistry, including preventative and general care, which encompasses routine check-ups, cleanings and comprehensive oral exams to maintain optimal dental health. Cosmetic dentistry services, such as teeth whitening, porcelain veneers and smile makeovers, are available to enhance the appearance of patients’ smiles. Restorative dentistry options include dental implants, crowns, bridges, and dentures to restore function and aesthetics. The clinic also provides periodontal therapy, which includes treatment for gum disease, scaling and root planing and advanced periodontal procedures. For patients who experience anxiety, sedation dentistry options are available to ensure a comfortable and stress-free dental experience. Additionally, Torrance Dentistry provides prompt treatment for dental emergencies to alleviate pain and address urgent issues. Utilizing advanced technology and state-of-the-art treatments, the clinic helps patients achieve healthy, balanced and beautiful smiles. Understanding the importance of accessibility, Torrance Dentistry strives to make dental care affordable for all patients. The clinic accepts many insurance plans and offers flexible financing options to ensure that everyone can receive the care they need.
